Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline

doi:10.1111/bjh.15235

Practice Guideline

. 2018 May;181(4):460-475.

doi: 10.1111/bjh.15235. Epub 2018 May 6.

Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline

Amrana Qureshi¹, Banu Kaya², Shivan Pancham³, Russell Keenan⁴, Jeremy Anderson⁵, Magbor Akanni⁶, Jo Howard⁷; British Society for Haematology

Affiliations

¹ Department of Paediatric Haematology and Oncology, Oxford Children's Hospital, Oxford University Hospital NHS Trust, Oxford, UK.
² Department of Paediatric Haematology and Oncology, Royal London Hospitals, Barts Health NHS Trust, London, UK.
³ Department of Haematology, Sandwell and West Birmingham NHS Trust, West Bromwich, UK.
⁴ Department of Paediatric Haematology, Alderhey Children's Hospital NHS Trust, Liverpool, UK.
⁵ Department of Clinical Psychology, Imperial College Healthcare NHS Trust, London, UK.
⁶ Department of Haematology, Milton Keynes Hospital NHS Trust, Milton Keynes, UK.
⁷ Department of Haematology, Guys and St Thomas's NHS Foundation Trust, London, UK.

PMID: 29732531
DOI: 10.1111/bjh.15235

Practice Guideline

Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline

Amrana Qureshi et al. Br J Haematol. 2018 May.

. 2018 May;181(4):460-475.

doi: 10.1111/bjh.15235. Epub 2018 May 6.

Authors

Amrana Qureshi¹, Banu Kaya², Shivan Pancham³, Russell Keenan⁴, Jeremy Anderson⁵, Magbor Akanni⁶, Jo Howard⁷; British Society for Haematology

Affiliations

¹ Department of Paediatric Haematology and Oncology, Oxford Children's Hospital, Oxford University Hospital NHS Trust, Oxford, UK.
² Department of Paediatric Haematology and Oncology, Royal London Hospitals, Barts Health NHS Trust, London, UK.
³ Department of Haematology, Sandwell and West Birmingham NHS Trust, West Bromwich, UK.
⁴ Department of Paediatric Haematology, Alderhey Children's Hospital NHS Trust, Liverpool, UK.
⁵ Department of Clinical Psychology, Imperial College Healthcare NHS Trust, London, UK.
⁶ Department of Haematology, Milton Keynes Hospital NHS Trust, Milton Keynes, UK.
⁷ Department of Haematology, Guys and St Thomas's NHS Foundation Trust, London, UK.

PMID: 29732531
DOI: 10.1111/bjh.15235

No abstract available

PubMed Disclaimer

Cited by

Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia.
Rankine-Mullings A, Keenan R, Chakravorty S, Inusa B, Telfer P, Velangi M, Ware RE, Moss JJ, Lloyd AL, Edwards S, Mulla H. Rankine-Mullings A, et al. Blood Adv. 2023 Aug 22;7(16):4319-4322. doi: 10.1182/bloodadvances.2023010099. Blood Adv. 2023. PMID: 37171600 Free PMC article. No abstract available.
Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease.
Hood AM, Crosby LE, Stotesbury H, Kölbel M, Kirkham FJ. Hood AM, et al. Front Neurol. 2022 Jun 21;13:835823. doi: 10.3389/fneur.2022.835823. eCollection 2022. Front Neurol. 2022. PMID: 35800079 Free PMC article. Review.
Clinical management of sickle cell liver disease in children and young adults.
Kyrana E, Rees D, Lacaille F, Fitzpatrick E, Davenport M, Heaton N, Height S, Samyn M, Mavilio F, Brousse V, Suddle A, Chakravorty S, Verma A, Gupte G, Velangi M, Inusa B, Drasar E, Hadzic N, Grammatikopoulos T, Hind J, Deheragoda M, Sellars M, Dhawan A. Kyrana E, et al. Arch Dis Child. 2021 Apr;106(4):315-320. doi: 10.1136/archdischild-2020-319778. Epub 2020 Nov 11. Arch Dis Child. 2021. PMID: 33177052 Free PMC article. Review.
Sickle Cell Disease-Genetics, Pathophysiology, Clinical Presentation and Treatment.
Inusa BPD, Hsu LL, Kohli N, Patel A, Ominu-Evbota K, Anie KA, Atoyebi W. Inusa BPD, et al. Int J Neonatal Screen. 2019 May 7;5(2):20. doi: 10.3390/ijns5020020. eCollection 2019 Jun. Int J Neonatal Screen. 2019. PMID: 33072979 Free PMC article. Review.
Clinical-Epidemiological Characteristics and Mortality in Patients with Sickle Cell Anemia: A Retrospective Cohort Study of 1980 at 2018.
Pompeo CM, Ferreira Júnior MA, Cardoso AIQ, Souza MDC, Frota OP, Mota FM, Ivo ML. Pompeo CM, et al. Int J Gen Med. 2022 Feb 2;15:1057-1074. doi: 10.2147/IJGM.S342971. eCollection 2022. Int J Gen Med. 2022. PMID: 35140508 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline

Affiliations

Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline

Authors

Affiliations

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical